RxDoctor Payments DataLook up a doctor →

Brian Gremillion, MD

Internal Medicine · Baton Rouge, LANPI 1326049545

Payments from drug & device makers

$27,274in general payments, 2019–2025

Across 1,629 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$2K
  • Boehringer Ingelheim$2K
  • Amgen$1K
  • plus $15K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk155$2,882
AbbVie(2 entities)195$2,419
AstraZeneca95$2,333
Lilly USA, LLC145$2,026
Boehringer Ingelheim104$1,570
Amgen69$1,210
GSK79$1,148
Pfizer81$1,048
Johnson & Johnson(2 entities)63$1,025
Teva Pharmaceuticals USA, Inc.68$1,018
Sanofi-aventis U.S. LLC45$760
Astellas Pharma US Inc38$704
Bayer24$585
Takeda Pharmaceuticals U.S.A., Inc.35$556
Novartis41$518
Merck33$449
Esperion Therapeutics, Inc.9$437
Lundbeck LLC19$424
Sunovion Pharmaceuticals Inc.16$406
Abbott21$396
Vanda Pharmaceuticals Inc.22$394
Axsome Therapeutics, Inc.7$333
Otsuka America Pharmaceutical, Inc.28$328
Avanir Pharmaceuticals, Inc.16$268
Medtronic(2 entities)6$265
Antares Pharma, Inc.16$264
Amarin Pharma, Inc.20$232
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$216
E.r. Squibb & Sons, L.L.C.9$201
Kowa Pharmaceuticals America, Inc.12$185
Acadia Pharmaceuticals Inc11$180
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$173
Urovant Sciences Inc5$169
Xeris Pharmaceuticals, Inc.8$160
Nevro Corp.2$123
Phathom Pharmaceuticals, Inc.8$108
Vivus LLC9$107
Eisai Inc.3$99
Gilead6$97
MDD US Operations, LLC1$91
Supernus Pharmaceuticals, Inc.7$90
Dexcom, Inc.4$85
Corcept Therapeutics4$81
Almatica Pharma LLC4$75
Sumitomo Pharma America, Inc.5$68
Ironwood Pharmaceuticals, Inc4$62
Genentech USA, Inc.3$61
Biogen3$59
Ardelyx, Inc.3$52
Neurocrine Biosciences, Inc.3$49
Tolmar, Inc.3$46
Sanofi Pasteur Inc.2$45
Currax Pharmaceuticals LLC3$43
IBSA Pharma Inc.2$42
Madrigal Pharmaceuticals2$39
Exact Sciences2$36
Alnylam Pharmaceuticals Inc.2$36
Corium, LLC3$28
Biohaven Pharmaceutical Holding Company Ltd.2$28
Rhythm Pharmaceuticals, Inc.1$27

How this compares

$27,274 in reported general payments places this provider in the 95th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$148,896
Medicare patients
524
Services billed
1,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Baton Rouge

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →